Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nicole Brighi
Observed names:
Brighi, Nicole,
N. Brighi
Institution:
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
Observed institutions:
University of Foggia,
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori,
Istituti di Ricovero e Cura a Carattere Scientifico,
University College London,
University of Bologna
show all 6
ORCID:
0000-0002-1187-5481
Observed ORCID:
0000-0002-1187-5481
OpenAlex ID:
A5081351022
Contrast-enhanced EUS for the characterization of mural nodules within pancreatic cystic neoplasms: systematic review and meta-analysis
2021
·
Andrea Lisotti
, Bertrand Napoleon
, et al.
·
Gastrointestinal Endoscopy
·
97
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues
2018
·
Sara Pusceddu
, Claudio Vernieri
, et al.
·
Gastroenterology
·
90
PDF
Correlation between MGMT promoter methylation and response to temozolomide-based therapy in neuroendocrine neoplasms: an observational retrospective multicenter study
2017
·
Davide Campana
, Thomas Walter
, et al.
·
Endocrine
·
79
Morphological Factors Related to Nodal Metastases in Neuroendocrine Tumors of the Appendix: A Multicentric Retrospective Study
2018
·
Nicole Brighi
, Stefano La Rosa
, et al.
·
Annals of Surgery
·
68
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
2024
·
Brigida Anna Maiorano
, Massimo Di Maio
, et al.
·
JAMA Network Open
·
61
The functioning side of the pancreas: a review on insulinomas
2019
·
I. Maggio
, V. Mollica
, et al.
·
Journal of Endocrinological Investigation
·
59
Heterogeneity of Duodenal Neuroendocrine Tumors: An Italian Multi-center Experience
2018
·
Sara Massironi
, Davide Campana
, et al.
·
Annals of Surgical Oncology
·
59
PDF
New Prognostic Biomarkers in Metastatic Castration-Resistant Prostate Cancer
2021
·
Vincenza Conteduca
, Alessandra Mosca
, et al.
·
Cells
·
54
PDF
Safety and efficacy of endoscopic ultrasound‐guided radiofrequency ablation for pancreatic neuroendocrine neoplasms: Systematic review and meta‐analysis
2023
·
Tawfik Khoury
, Wisam Sbeit
, et al.
·
Digestive Endoscopy
·
51
The Role of mTOR in Neuroendocrine Tumors: Future Cornerstone of a Winning Strategy?
2018
·
Giuseppe Lamberti
, Nicole Brighi
, et al.
·
International Journal of Molecular Sciences
·
51
PDF
Cancer in the elderly: Is it time for palliative care in geriatric oncology?
2014
·
Nicole Brighi
, Lodovico Balducci
, et al.
·
Journal of Geriatric Oncology
·
47
Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study
2016
·
Davide Campana
, Davide Ravizza
, et al.
·
Endocrine
·
45
Nonconventional Doses of Somatostatin Analogs in Patients With Progressing Well-Differentiated Neuroendocrine Tumor
2019
·
Giuseppe Lamberti
, Antongiulio Faggiano
, et al.
·
The Journal of Clinical Endocrinology & Metabolism
·
44
PDF
Flare phenomenon in prostate cancer: recent evidence on new drugs and next generation imaging
2021
·
Vincenza Conteduca
, Giulia Poti
, et al.
·
Therapeutic Advances in Medical Oncology
·
41
PDF
Biliary stone disease in patients receiving somatostatin analogs for neuroendocrine neoplasms. A retrospective observational study
2018
·
Nicole Brighi
, Giuseppe Lamberti
, et al.
·
Digestive and Liver Disease
·
41
Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study
2019
·
Nicole Brighi
, Francesco Panzuto
, et al.
·
The Oncologist
·
37
Immunotherapy and Its Development for Gynecological (Ovarian, Endometrial and Cervical) Tumors: From Immune Checkpoint Inhibitors to Chimeric Antigen Receptor (CAR)-T Cell Therapy
2021
·
Giuseppe Schepisi
, Chiara Casadei
, et al.
·
Cancers
·
32
PDF
The cyclin-dependent kinases pathway as a target for prostate cancer treatment: rationale and future perspectives
2020
·
Nicole Brighi
, Vincenza Conteduca
, et al.
·
Critical Reviews in Oncology/Hematology
·
32
Contrast-enhanced endoscopic ultrasound for the differential diagnosis between benign and malignant lymph nodes: a meta-analysis
2019
·
Andrea Lisotti
, Claudio Ricci
, et al.
·
Endoscopy International Open
·
32
PDF
Histopathological diagnosis of appendiceal neuroendocrine neoplasms: when to perform a right hemicolectomy? A systematic review and meta-analysis
2019
·
Claudio Ricci
, Carlo Ingaldi
, et al.
·
Endocrine
·
31
The Interplay between Inflammation, Anti-Angiogenic Agents, and Immune Checkpoint Inhibitors: Perspectives for Renal Cell Cancer Treatment
2019
·
Nicole Brighi
, Alberto Farolfi
, et al.
·
Cancers
·
28
PDF
Prognostic impact of tumour burden in stage IV neuroendocrine neoplasia: A comparison between pancreatic and gastrointestinal localizations
2019
·
Francesco Panzuto
, Sara Pusceddu
, et al.
·
Pancreatology
·
28
Prospective Evaluation of MGMT-Promoter Methylation Status and Correlations with Outcomes to Temozolomide-Based Chemotherapy in Well-Differentiated Neuroendocrine Tumors
2023
·
Nicole Brighi
, Giuseppe Lamberti
, et al.
·
Current Oncology
·
24
177Lu-PSMA therapy in metastatic prostate cancer: An updated review of prognostic and predictive biomarkers
2024
·
Emilio Francesco Giunta
, Nicole Brighi
, et al.
·
Cancer Treatment Reviews
·
23
PDF
A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors
2018
·
Sara Pusceddu
, Francesco Barretta
, et al.
·
Endocrine Related Cancer
·
23
PDF
Show more works
View as search
Works count:
138
Citation count:
1,706
H-index:
23
I10-index:
48
Year
Topic
Type